117 related articles for article (PubMed ID: 12461781)
21. Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
Hemminki K; Chen B
Melanoma Res; 2006 Apr; 16(2):191-5. PubMed ID: 16567975
[TBL] [Abstract][Full Text] [Related]
22. The retinoblastoma protein and cell cycle regulation.
Hamel PA; Gallie BL; Phillips RA
Trends Genet; 1992 May; 8(5):180-5. PubMed ID: 1369744
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of the p53 pathway in retinoblastoma.
Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
[TBL] [Abstract][Full Text] [Related]
25. pRB induces Sp1 activity by relieving inhibition mediated by MDM2.
Johnson-Pais T; Degnin C; Thayer MJ
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2211-6. PubMed ID: 11226218
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
27. The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein.
Derenzini M; Brighenti E; Donati G; Vici M; Ceccarelli C; Santini D; Taffurelli M; Montanaro L; Treré D
J Pathol; 2009 Nov; 219(3):373-82. PubMed ID: 19731257
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of RB1 mutations in argentine patients: 20-years experience in the molecular diagnosis of retinoblastoma.
Ottaviani D; Parma D; Giliberto F; Ferrer M; Fandino A; Davila MT; Chantada G; Szijan I
Ophthalmic Genet; 2013 Dec; 34(4):189-98. PubMed ID: 23301675
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
30. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
Brynes RK; Wilson CS; Kim AB; McCourty A
Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
[TBL] [Abstract][Full Text] [Related]
32. The retinoblastoma gene and its significance.
Schubert EL; Hansen MF; Strong LC
Ann Med; 1994 Jun; 26(3):177-84. PubMed ID: 8074836
[TBL] [Abstract][Full Text] [Related]
33. Molecular biology of the human retinoblastoma gene.
Lee WH; Bookstein RE; Lee EY
Immunol Ser; 1990; 51():169-200. PubMed ID: 1965700
[No Abstract] [Full Text] [Related]
34. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
35. The retinoblastoma protein: more than a tumor suppressor.
Riley DJ; Lee EY; Lee WH
Annu Rev Cell Biol; 1994; 10():1-29. PubMed ID: 7888173
[No Abstract] [Full Text] [Related]
36. A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1.
Eloy P; Dehainault C; Sefta M; Aerts I; Doz F; Cassoux N; Lumbroso le Rouic L; Stoppa-Lyonnet D; Radvanyi F; Millot GA; Gauthier-Villars M; Houdayer C
PLoS Genet; 2016 Feb; 12(2):e1005888. PubMed ID: 26925970
[TBL] [Abstract][Full Text] [Related]
37. Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number.
Galteland E; Smedshammer L; Suo Z; DeAngelis P; Stokke T
Leukemia; 2002 Aug; 16(8):1549-55. PubMed ID: 12145697
[TBL] [Abstract][Full Text] [Related]
38. The role of the retinoblastoma gene in breast cancer development.
Fung YK; T'Ang A
Cancer Treat Res; 1992; 61():59-68. PubMed ID: 1360245
[TBL] [Abstract][Full Text] [Related]
39. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.
Dimaras H; Khetan V; Halliday W; Orlic M; Prigoda NL; Piovesan B; Marrano P; Corson TW; Eagle RC; Squire JA; Gallie BL
Hum Mol Genet; 2008 May; 17(10):1363-72. PubMed ID: 18211953
[TBL] [Abstract][Full Text] [Related]
40. Costenbader Memorial Lecture: Genesis and genetics of retinoblastoma.
François J
Adv Ophthalmol; 1979; 39():181-209. PubMed ID: 394592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
